Opioid-Induced Respiratory Depression Market to Expand Substantially Owing to Technological Innovations During 2019 - 2029
Download sample copy of this report:
Opioid-Induced Respiratory Depression: Market Dynamics
Over 15 thousand Americans die every year from respiratory depression due to an overdose of opioids. The development of new sophisticated treatments to treat opioid-induced respiratory depression is one of the major areas of research. Currently, there are mainly two approaches developed, one approach is the opioids design with minimal respiratory effect and the other is the use of drugs that stimulate breathing through non-opioidergic pathways. And there are no pharmacological strategies available to prevent respiratory depression without changing opioid analgesia. This opioid-induced respiratory depression field provide great opportunities for researchers and manufacturers and is expected to boost the growth of opioid-induced respiratory depression market.
Opioid-Induced Respiratory Depression market: Segmentation
The global opioid-induced respiratory depression market is segmented by product type, end user and regions:
Opioid-Induced Respiratory Depression Segmentation by Product Type Pulse Oximeter Capnographs Audiometry Integrated Delivery and Monitoring Devices Acoustic Monitor Radar Monitor Bioimpedance Device Inductance Plethysmograph Others
Opioid-Induced Respiratory Depression Segmentation by End User Hospital Ambulatory Surgical Center Specialty Clinic Diagnostic Center Others
Opioid-Induced Respiratory Depression market: Overview
The Anesthesia Patient Safety Foundation has convened multidisciplinary conferences in 2006 and 2011, to address the safety issue for the serious patient with opioid-induced respiratory depression. Today, the administration of naloxone is the only treatment for an opioid overdose. Capnograph is an important device to help healthcare providers in initial assessments of patients to measure the management of naloxone therapy. Accurately measurement of the opioid-induced respiratory depression has been a challenge. To consequently measure the safety advantage of a new monitoring protocol or technology is also very difficult. Lack of research and inconsistent taxonomy for opioid-induced respiratory depression may hinder the opioid-induced respiratory depression market.
Opioid-Induced Respiratory Depression market: Region-wise Outlook
The opioid-induced respiratory depression market in North America is expected to show the highest revenue growth and to hold the largest market shares in the global opioid-induced respiratory depression market due to advanced healthcare infrastructure and high healthcare spending. Additionally, high rate of opioid consumption in this region will boost the opioid-induced respiratory depression market, followed by Europe. The opioid-induced respiratory depression market in the Asia-Pacific region is expected to register the moderate growth due to low healthcare facilities and large untreated patient pool. Whereas, Latin America and the Middle East & Africa are expected to show stagnant opioid-induced respiratory depression market growth due to weak healthcare management and facilities.
Buy Now to Get 10% Off and Free Customization as per Requirement:
Opioid-Induced Respiratory Depression market: Key Players
Some of the key players present in global opioid-induced respiratory depression market are Medtronic plc, Smiths Group, Masimo Corporation, Nihon Kohden Corporation, Covidien, GE Healthcare, Welch Allyn, Becton, Dickinson and Company, BioMed Jena GmbH, Hill-Rom, Inc., Natus Medical Incorporated and others.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Opioid-Induced Respiratory Depression Market to Expand Substantially Owing to Technological Innovations During 2019 - 2029 here
News-ID: 1806863 • Views: 371
More Releases from Future Market Insights
Drug of Abuse Testing Market Complete Analytical Report for 2029 with Key Player …
A recent market study published by Future Market Insights on the drug of abuse testing market includes global industry analysis 2014-2018 & opportunity assessment 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the drug of abuse testing market, the growth prospects of the market are obtained with maximum precision. Drug of Abuse
Global Phytopathological Disease Diagnostics Market Things to Focus on to Ensure …
A recent market study published by Future Market Insights (FMI) on the phytopathological disease diagnostics including global industry analysis of 2014-2018 and opportunity assessment for 2019-2029, delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical as well as current growth parameters of the phytopathological disease diagnostics market, growth prospects are obtained with maximum precision. Phytopathological Disease Diagnostics Market: Segmentation The global phytopathological disease diagnostics
Electronic Stethoscope Market Size, Growth Analysis Report, Forecast to 2029 | M …
The electronic stethoscopes market is expected to witness significant growth in the near future. Amplifying electronic stethoscopes are the most widely used stethoscopes for auscultation. Electronic stethoscopes amplify respiratory/cardiac sound. They also help medical professionals who suffer from hearing problems. Report Description Chapter 1 – Executive Summary The report commences with an executive summary that consists of a summary of the key findings and statistics related to the electronic stethoscopes market. Chapter 2 –
Gaskets and Seals :Impact Of Covid-19 On Market Demand And Future Scope With Top …
Future Market Insights in its latest report titled ‘Gaskets and Seals Market: Global Industry Analysis and Opportunity Assessment, 2016–2026’ presents a comprehensive and a detailed outlook of the global gaskets and seals market for a 10 year period from 2016 to 2026. In this report, various factors that influence the global gaskets and seals market have been studied in detail and region wise gaskets and seals market analysis and forecast
More Releases for Respiratory
Global Respiratory Exerciser Market Research Report
This report studies the global Respiratory Exerciser market status and forecast, categorizes the global Respiratory Exerciser market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Becton Dickinson Cardinal Health Smiths Medical Nidek Medical India Teleflex Incorporated Kompaniya Dinamika Wintersweet Medical Boen Healthcare
Respiratory Analysers Market size and forecast-2026
In the field of medicine, anaesthesia is a temporary state induced to cause amnesia, paralysis, and unconsciousness. The main objective is to enable a surgeon to perform a procedure which would cause the patient immense and intolerable pain without it. While it has enabled the saving of lives on many an occasion, it is not completely risk free. Minor risks include nausea, vomiting while major ones can include a heart
Respiratory therapeutic devices market Future Trends 2023
The Global Respiratory therapeutic devices Market Research Report provides detailed analysis of the key regional market status of the Respiratory therapeutic devices Industry. Asia Pacific Respiratory Therapeutic Devices Market information, By Devices (Nebulizers, Humidifiers, Oxygen Concentrators, Ventilators, Gas Analyzers, Capnographs, positive airway pressure (PAP), and others), by technology (Electrostatic Filtration, HEPA Filter, Hollow Fiber Filtration, Microsphere Separation and others) and by end user (Hospital and Homecare) -Forecast to 2023 Market Scenario: Respiratory therapeutic
Respiratory Monitoring Devices Market | Analysis & Trends 2023
While a handful players have taken up a majority share in The Global Distribution Of Respiratory Monitoring Devices, the remainder of the market is marked by a very large number of small players. Of the key multinationals dominating the distribution of respiratory monitoring devices in 2014, CareFusion Corporation, Smiths Medical, and ResMed, Inc., had garnered a total share of 54.2% in terms of value. As described in a research report released
Respiratory Monitoring Devices Industry Trends
Global Respiratory Monitoring Devices Market: Snapshot Factors at the forefront of driving the demand in the global respiratory monitoring devices market are the rising number of cigarette smokers and a worsening air quality on account of rampant pollution. Further, a burgeoning geriatric population highly susceptible to lung diseases has also pushed up the demand in the market. Countering its growth, however, are the steep prices of newer, sophisticated respiratory monitoring devices,
Respiratory Monitoring Devices Market 2015
While a handful players have taken up a majority share in the global distribution of respiratory monitoring devices, the remainder of the market is marked by a very large number of small players. Of the key multinationals dominating the distribution of respiratory monitoring devices in 2014, CareFusion Corporation, Smiths Medical, and ResMed, Inc., had garnered a total share of 54.2% in terms of value. As described in a research report released